InvestorsHub Logo
Followers 483
Posts 61650
Boards Moderated 14
Alias Born 09/20/2001

Re: bas2020 post# 65384

Friday, 06/17/2016 8:30:39 AM

Friday, June 17, 2016 8:30:39 AM

Post# of 471108
Makes it clear - Solanezumab only expected to "slow the course of the disease". Because of this the trial must be more detailed in its stats and longer to prove endoint than say, a drug that shows clear cognitive reversal of the disease.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News